5 results on '"Lisi, Daniela Di"'
Number of results to display per page
Search Results
2. 174 EVALUATION OF SUBCLINICAL RIGHT VENTRICULAR CARDIOTOXICITY BY ADVANCED ECHOCARDIOGRAPHY IN PATIENTS WITH BREAST CANCER TREATED WITH ANTHRACYCLINES
- Author
-
Gambino, Grazia, primary, Lisi, Daniela Di, additional, Palermo, Antonio Di, additional, Triolo, Oreste Fabio, additional, Rossetto, Ludovico, additional, Myriam Intravaia, Rita Cristina, additional, Buccheri, Giancarlo, additional, Passavanti, Giulia, additional, Galassi, Alfredo Ruggero, additional, and Novo, Giuseppina, additional
- Published
- 2022
- Full Text
- View/download PDF
3. Reshaping of Italian Echocardiographic Laboratories Activities during the Second Wave of COVID-19 Pandemic and Expectations for the Post-Pandemic Era
- Author
-
Ciampi, Quirino, Antonini-Canterin, Francesco, Barbieri, Andrea, Barchitta, Agata, Benedetto, Frank, Cresti, Alberto, Miceli, Sofia, Monte, Ines, Petrella, Licia, Trocino, Giuseppe, Aquila, Iolanda, Barbati, Giovanni, Barletta, Valentina, Barone, Daniele, Beraldi, Monica, Bergandi, Gianluigi, Bilardo, Giuseppe, Boriani, Giuseppe, Bossone, Eduardo, Bongarzoni, Amedeo, Bovolato, Francesca, Bursi, Francesca, Cammalleri, Valeria, Carbonella, Marco, Casavecchia, Grazia, Cicco, Sebastiano, Cioffi, Giovanni, Cocchia, Rosangela, Colonna, Paolo, Cortigiani, Lauro, Cucchini, Umberto, D'Alfonso, Maria, D’Andrea, Antonello, Dell'Angela, Luca, Dentamaro, Ilaria, Paolis, Marcella De, Stefanis, Paola De, Deste, Wanda, Fulvio, Maria Di, Giannuario, Giovanna Di, Lisi, Daniela Di, Nora, Concetta Di, Fabiani, Iacopo, Esposito, Roberta, Fazzari, Fabio, Ferrara, Luigi, Filice, Gemma, Forno, Davide, Giorgi, Mauro, Giustiniano, Enrico, Greco, Cosimo, Iannuzzi, Gian, Izzo, Annibale, Lanzone, Alberto, Malagoli, Alessandro, Mantovani, Francesca, Manuppelli, Vincenzo, Mega, Simona, Merli, Elisa, Ministeri, Margherita, Morrone, Doralisa, Napoletano, Cosimo, Nunziata, Luigi, Pastorini, Guido, Pedone, Chiara, Petruccelli, Enrica, Polito, Maria, Polizzi, Vincenzo, Prota, Costantina, Rigo, Fausto, Rivaben, Dante, Saponara, Silvio, Sciacqua, Angela, Sartori, Chiara, Scarabeo, Virginia, Serra, Walter, Severino, Sergio, Spinelli, Luciano, Tamborini, Gloria, Tota, Antonio, Villari, Bruno, Carerj, Scipione, Picano, Eugenio, Pepi, Mauro, (SIECVI), SIECoVId Study Group, on Behalf of the Italian Society of Echocardiography and Cardiovascular Imaging, Ciampi, Q., Antonini-Canterin, F., Barbieri, A., Barchitta, A., Benedetto, F., Cresti, A., Miceli, S., Monte, I., Petrella, L., Trocino, G., Aquila, I., Barbati, G., Barletta, V., Barone, D., Beraldi, M., Bergandi, G., Bilardo, G., Boriani, G., Bossone, E., Bongarzoni, A., Bovolato, F. E., Bursi, F., Cammalleri, V., Carbonella, M., Casavecchia, G., Cicco, S., Cioffi, G., Cocchia, R., Colonna, P., Cortigiani, L., Cucchini, U., D'Alfonso, M. G., D'Andrea, A., Dell'Angela, L., Dentamaro, I., De Paolis, M., De Stefanis, P., Deste, W., Di Fulvio, M., Di Giannuario, G., Di Lisi, D., Di Nora, C., Fabiani, I., Esposito, R., Fazzari, F., Ferrara, L., Filice, G., Forno, D., Giorgi, M., Giustiniano, E., Greco, C. A., Iannuzzi, G. L., Izzo, A., Lanzone, A. M., Malagoli, A., Mantovani, F., Manuppelli, V., Mega, S., Merli, E., Ministeri, M., Morrone, D., Napoletano, C., Nunziata, L., Pastorini, G., Pedone, C., Petruccelli, E., Polito, M. V., Polizzi, V., Prota, C., Rigo, F., Rivaben, D. E., Saponara, S., Sciacqua, A., Sartori, C., Scarabeo, V., Serra, W., Severino, S., Spinelli, L., Tamborini, G., Tota, A., Villari, B., Carerj, S., Picano, E., and Pepi, M.
- Subjects
medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,COVID-19 ,Lung ultrasound ,Point-of-care cardiac ultrasound ,Carbon dioxide production ,Article ,Settore MED/11 ,Internal medicine ,Pandemic ,Stress Echocardiography ,Medicine ,echocardiography ,Cardiac imaging ,COVID-19, lung ultrasound, point-of-care cardiac ultrasound ,lung ultrasound ,point-of-care cardiac ultrasound ,business.industry ,speckle tracking multilayer ,General Medicine ,echocardiography, speckle tracking multilayer ,Cardiology ,Cardiac Imaging Techniques ,business ,Personal protection equipment - Abstract
Background: Cardiology divisions reshaped their activities during the coronavirus disease 2019 (COVID-19) pandemic. This study aimed to analyze the organization of echocardiographic laboratories and echocardiography practice during the second wave of the COVID-19 pandemic in Italy, and the expectations for the post-COVID era. Methods: We analyzed two different time periods: the month of November during the second wave of the COVID-19 pandemic (2020) and the identical month during 2019 (November 2019). Results: During the second wave of the COVID-19 pandemic, the hospital activity was partially reduced in 42 (60%) and wholly interrupted in 3 (4%) echocardiographic laboratories, whereas outpatient echocardiographic activity was partially reduced in 41 (59%) and completely interrupted in 7 (10%) laboratories. We observed an important change in the organization of activities in the echocardiography laboratory which reduced the operator-risk and improved self-protection of operators by using appropriate personal protection equipment. Operators wore FFP2 in 58 centers (83%) during trans-thoracic echocardiography (TTE), in 65 centers (93%) during transesophageal echocardiography (TEE) and 63 centers (90%) during stress echocardiography. The second wave caused a significant reduction in number of echocardiographic exams, compared to November 2019 (from 513 ± 539 to 341 ± 299 exams per center, −34%, p <, 0.001). On average, there was a significant increase in the outpatient waiting list for elective echocardiographic exams (from 32.0 ± 28.1 to 45.5 ± 44.9 days, +41%, p <, 0.001), with a reduction of in-hospital waiting list (2.9 ± 2.4 to 2.4 ± 2.0 days, −17%, p <, 0.001). We observed a large diffusion of point-of-care cardiac ultrasound (88%), with a significant increase of lung ultrasound usage in 30 centers (43%) during 2019, extended to all centers in 2020. Carbon dioxide production by examination is an indicator of the environmental impact of technology (100-fold less with echocardiography compared to other cardiac imaging techniques). It was ignored in 2019 by 100% of centers, and currently it is considered potentially crucial for decision-making in cardiac imaging by 65 centers (93%). Conclusions: In one year, major changes occurred in echocardiography practice and culture. The examination structure changed with extensive usage of point-of-care cardiac ultrasound and with lung ultrasound embedded by default in the TTE examination, as well as the COVID-19 testing.
- Published
- 2021
- Full Text
- View/download PDF
4. PREDICTIVE PARAMETERS OF VENTRICULAR ARRHYTHMIAS IN ACUTE MYOCARDITIS WITH PRESERVED LVEF
- Author
-
Novo, Giuseppina, primary, LISI, DANIELA DI, additional, Bellavia, Diego, additional, Franca, Eluisa La, additional, Carmina, Maria Gabriella, additional, Novo, Salvatore, additional, Bella, Gianluca Di, additional, and Clemenza, Francesco, additional
- Published
- 2021
- Full Text
- View/download PDF
5. The new HFA/ICOS risk assessment tool to identify patients with chronic myeloid leukaemia at high risk of cardiotoxicity.
- Author
-
Lisi, Daniela Di, Madaudo, Cristina, Alagna, Giulia, Santoro, Marco, Rossetto, Ludovico, Siragusa, Sergio, and Novo, Giuseppina
- Subjects
CHRONIC myeloid leukemia ,RISK assessment ,DISEASE risk factors ,CARDIOTOXICITY ,PROTEIN-tyrosine kinase inhibitors - Abstract
Aims Tyrosine kinase inhibitors (TKIs) used to treat chronic myeloid leukaemia (CML) can cause cardiovascular adverse events. So far, the Systematic Coronary Risk Evaluation (SCORE) charts of the European Society of Cardiology (ESC) have been used to identify cancer patients at increased cardiovascular risk. The primary aim of our study was to evaluate the usefulness of the new cardiovascular risk assessment model proposed by the Cardio-Oncology Study Group of the Heart Failure Association (HFA) of the ESC in collaboration with the International Cardio-Oncology Society (ICOS) to stratify the cardiovascular risk in CML patients, compared with SCORE risk charts. The secondary aim was to establish the incidence of adverse arterial events (AEs) in patients with CML treated with TKIs and the influence of preventive treatment with aspirin. Methods and results A retrospective single-centre observational study was carried out on 58 patients (32 men and 26 women; mean age ± SD: 59 ± 15 years) with CML treated with TKIs for a median period of 43 ± 31 months. Cardiological evaluation was performed and cardiovascular risk was estimated with SCORE risk charts and with the new risk assessment tool proposed by HFA/ICOS. AEs were recorded. According to SCORE charts and the new HFA/ICOS risk stratification tool, respectively, 46% (Group A1) and 60% (Group A2) of patients were at high–very high risk, and 54% (Group B1) and 40% (Group B2) at low–moderate risk. AEs were significantly more frequent in Group A1 than Group B1 (P value < 0.01) when considered overall; they were significantly more frequent in Group A2 than Group B2 either overall or considered individually. HFA/ICOS risk stratification tool was significantly more sensitive than SCORE (P < 0.01) in identifying patients at higher risk of cardiovascular toxicity. In addition, we did not find AEs in patients pretreated with aspirin. Conclusions The new HFA/ICOS risk stratification model allows a more tailored cardiovascular risk stratification in patients with CML and it is more sensitive than SCORE charts. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.